A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

NCT00046176 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus I
HIV Infection

Interventions

DRUG: abacavir/lamivudine
DRUG: abacavir
DRUG: lamivudine

Sponsor

ViiV Healthcare